|
12 Companies |
|
14 Products |
|
14 Products |
|
7 Mechanisms of Action |
|
0 Trials |
|
9 News |
|
- | Trial completion: Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 1, 2016
P2, N=0, Completed, Sponsor: AIDS Malignancy Consortium
No longer recruiting --> Completed
- Enrollment change, Trial withdrawal, Gene therapy: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (clinicaltrials.gov) - May 7, 2015
P=N/A, N=0, Withdrawn, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed N=13 --> 0 | Not yet recruiting --> Withdrawn
- Trial initiation date, Gene therapy: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=13, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
N=13 --> 0 | Not yet recruiting --> Withdrawn Initiation date: Oct 2014 --> Feb 2015
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=38, Completed, Sponsor: Eastern Cooperative Oncology Group
Initiation date: Oct 2014 --> Feb 2015 Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk, Matulane (procarbazine hydrochloride) / Leadiant Biosci
Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease (clinicaltrials.gov) - Feb 19, 2014
P2, N=5, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date, Gene therapy: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (clinicaltrials.gov) - Jan 1, 2014
P=N/A, N=13, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Initiation date: Oct 2013 --> Oct 2014
- Trial withdrawal: Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Jan 21, 2013
P2, N=0, Withdrawn, Sponsor: AIDS Malignancy Clinical Trials Consortium
Initiation date: Oct 2013 --> Oct 2014 Completed --> Withdrawn
- Gene therapy: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (clinicaltrials.gov) - Jan 15, 2013
P=N/A, N=13, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
- zidovudine / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion: SWOG 9320: SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Jan 11, 2012
P2, N=52, Completed, Sponsor: Southwest Oncology Group
Completed --> Withdrawn Active, not recruiting --> Completed